|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Derma Sciences Inc., a manufacturer of advanced wound care products. |
|---|---|
| Transferring Party | NutraMax, a manufacturer of a variety of health related products. |
| Sector | Medical Devices |
| Date | November 13, 2007 |
| Analysis Acquired lines have a #2 market share position in private label adhesive strips, a $86m market with notable growth. The deal is expect to increase Derma Sciences' annual revenues to over $50m and significantly enhance its base of manufacturing in the wound care field. Deal value -- $13m on sales of $17m, with expected 08 cash flow contribution of $3.5m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |